Wikipedia:WikiProject Medicine/Cochrane/Cochrane Review List/Cancer/Urology Group/Raw Search Results
Appearance
RAW SEARCH RESULTS- APRIL 6 2021 (COMPARES EN.WIKIPEDIA WITH THE COCHRANE LIBRARY). SET TO INCLUDE REVIEWS UPDATED OR PUBLISHED IN THE PAST 10 YEARS.
FALSE= Not yet shared on Wikipedia TRUE= Shared on en.Wikipedia
10.1002/14651858.CD012799.pub2 | Mar-21 | Selective serotonin re-uptake inhibitors for premature ejaculation in adult men | Urology Group | 33745183 | FALSE |
10.1002/14651858.CD012250.pub2 | Mar-21 | Circumcision devices versus standard surgical techniques in adolescent and adult male circumcisions | Urology Group | 33786810 | FALSE |
10.1002/14651858.CD012336.pub2 | Feb-21 | Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction | Urology Group | 33567116 | FALSE |
10.1002/14651858.CD013251.pub2 | Mar-20 | Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia | Urology Group | 32212174 | FALSE |
10.1002/14651858.CD006250.pub2 | Dec-17 | Bisphosphonates for advanced prostate cancer | Urology Group | 29278410 | FALSE |
10.1002/14651858.CD011252.pub2 | Nov-17 | Medical and dietary interventions for preventing recurrent urinary stones in children | Urology Group | 29117629 | FALSE |
10.1002/14651858.CD012615.pub2 | Nov-17 | Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia | Urology Group | 29161773 | FALSE |
10.1002/14651858.CD012059.pub2 | Oct-17 | Desmopressin for treating nocturia in men | Urology Group | 29055129 | FALSE |
10.1002/14651858.CD011864.pub2 | Sep-17 | Intravesical electromotive drug administration for non-muscle invasive bladder cancer | Urology Group | 28898400 | FALSE |
10.1002/14651858.CD012111.pub2 | May-17 | Alvimopan for recovery of bowel function after radical cystectomy | Urology Group | 28462518 | FALSE |
10.1002/14651858.CD011673.pub2 | May-17 | Immunotherapy for metastatic renal cell carcinoma | Urology Group | 28504837 | FALSE |
10.1002/14651858.CD012045.pub2 | May-17 | Partial nephrectomy versus radical nephrectomy for clinical localised renal masses | Urology Group | 28485814 | FALSE |
10.1002/14651858.CD012112.pub2 | Mar-17 | Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer | Urology Group | 28268259 | FALSE |
10.1002/14651858.CD010716.pub2 | Jul-16 | Surgery versus non-surgical management for unilateral ureteric-pelvic junction obstruction in newborns and infants less than two years of age | Urology Group | 27416073 | FALSE |
10.1002/14651858.CD010057.pub2 | Oct-15 | Citrate salts for preventing and treating calcium containing kidney stones in adults | Urology Group | 26439475 | FALSE |
10.1002/14651858.CD009735.pub2 | Nov-14 | Aspiration and sclerotherapy versus hydrocoelectomy for treating hydrocoeles | Urology Group | 25391386 | FALSE |
10.1002/14651858.CD009266.pub2 | Jun-14 | Non-steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer | Urology Group | 24979481 | FALSE |
10.1002/14651858.CD006022.pub4 | Feb-14 | Dietary interventions for preventing complications in idiopathic hypercalciuria | Urology Group | 24519664 | FALSE |
10.1002/14651858.CD008569.pub2 | Dec-13 | Percussion, diuresis, and inversion therapy for the passage of lower pole kidney stones following shock wave lithotripsy | Urology Group | 24318643 | FALSE |
10.1002/14651858.CD008529.pub3 | Dec-13 | Psychosocial interventions for men with prostate cancer | Urology Group | 24368598 | FALSE |
10.1002/14651858.CD009071.pub2 | Aug-13 | Antimicrobial therapy for chronic bacterial prostatitis | Urology Group | 23934982 | FALSE |
10.1002/14651858.CD009063.pub2 | Aug-12 | Pregabalin for chronic prostatitis | Urology Group | 22895982 | FALSE |
10.1002/14651858.CD006029.pub4 | May-12 | Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi | Urology Group | 22592707 | FALSE |
10.1002/14651858.CD004926.pub3 | Feb-12 | Fluids and diuretics for acute ureteric colic | Urology Group | 22336806 | FALSE |
10.1002/14651858.CD009294.pub2 | Jan-12 | Intravesical gemcitabine for non-muscle invasive bladder cancer | Urology Group | 22259002 | FALSE |
10.1002/14651858.CD007234.pub2 | Dec-11 | Adjuvant radiotherapy following radical prostatectomy for prostate cancer | Urology Group | 22161411 | FALSE |
10.1002/14651858.CD008195.pub2 | Aug-11 | Psychosocial interventions for premature ejaculation | Urology Group | 21833964 | FALSE |
10.1002/14651858.CD008871.pub2 | Jul-11 | Low-dose rate brachytherapy for men with localized prostate cancer | Urology Group | 21735436 | FALSE |
10.1002/14651858.CD006885.pub2 | May-11 | Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer | Urology Group | 21563157 | FALSE |
10.1002/14651858.CD008976.pub2 | Apr-11 | Gemcitabine for unresectable, locally advanced or metastatic bladder cancer | Urology Group | 21491413 | FALSE |
10.1002/14651858.CD007349.pub2 | Apr-11 | Surgical management for upper urinary tract transitional cell carcinoma | Urology Group | 21491399 | FALSE |
10.1002/14651858.CD012867.pub2 | Dec-20 | Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia | Urology Group | 33368143 | TRUE |
10.1002/14651858.CD013020.pub2 | Dec-20 | Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis | Urology Group | 33270906 | TRUE |
10.1002/14651858.CD013245.pub2 | Dec-20 | Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer | Urology Group | 33314020 | TRUE |
10.1002/14651858.CD013393.pub2 | Nov-20 | Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults | Urology Group | 33179245 | TRUE |
10.1002/14651858.CD012796.pub2 | Oct-20 | Targeted therapy for metastatic renal cell carcinoma | Urology Group | 33058158 | TRUE |
10.1002/14651858.CD013641.pub2 | Aug-20 | Retzius-sparing versus standard robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer. | Urology Group | 32813279 | TRUE |
10.1002/14651858.CD006590.pub3 | Jun-20 | Radical prostatectomy versus deferred treatment for localised prostate cancer | Urology Group | 32495338 | TRUE |
10.1002/14651858.CD004292.pub4 | Feb-20 | Water for preventing urinary stones | Urology Group | 32045491 | TRUE |
10.1002/14651858.CD011935.pub2 | Jan-20 | Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer | Urology Group | 31912907 | TRUE |
10.1002/14651858.CD009629.pub4 | Dec-19 | Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction | Urology Group | 31792928 | TRUE |
10.1002/14651858.CD010784.pub3 | Oct-19 | Medical and surgical interventions for the treatment of urinary stones in children | Urology Group | 31596944 | TRUE |
10.1002/14651858.CD012552.pub2 | Oct-19 | Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome | Urology Group | 31587256 | TRUE |
10.1002/14651858.CD011462.pub2 | Sep-19 | Hypofractionation for clinically localized prostate cancer | Urology Group | 31476800 | TRUE |
10.1002/14651858.CD003506.pub2 | Jun-19 | Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer | Urology Group | 31194882 | TRUE |
10.1002/14651858.CD013336 | May-19 | Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy | Urology Group | 31111956 | TRUE |
10.1002/14651858.CD010127.pub2 | May-19 | Perioperative nutrition for the treatment of bladder cancer by radical cystectomy | Urology Group | 31107970 | TRUE |
10.1002/14651858.CD013160.pub2 | May-19 | Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma | Urology Group | 31102534 | TRUE |
10.1002/14651858.CD012832.pub2 | May-19 | Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia | Urology Group | 31128077 | TRUE |
10.1002/14651858.CD012663.pub2 | Apr-19 | Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer | Urology Group | 31022301 | TRUE |
10.1002/14651858.CD012044.pub2 | Apr-19 | Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction | Urology Group | 30953341 | TRUE |
10.1002/14651858.CD011903.pub2 | Apr-19 | Robotic versus open radical cystectomy for bladder cancer in adults | Urology Group | 31016718 | TRUE |
10.1002/14651858.CD012305.pub2 | Feb-19 | Antimicrobial agents for preventing urinary tract infections in adults undergoing cystoscopy | Urology Group | 30789676 | TRUE |
10.1002/14651858.CD013143.pub2 | Feb-19 | Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia | Urology Group | 30759311 | TRUE |
10.1002/14651858.CD012703.pub2 | Feb-19 | Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi | Urology Group | 30726554 | TRUE |
10.1002/14651858.CD010060.pub2 | Nov-18 | Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia | Urology Group | 30480763 | TRUE |
10.1002/14651858.CD012816.pub2 | Oct-18 | Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer | Urology Group | 30320443 | TRUE |
10.1002/14651858.CD007360.pub3 | Oct-18 | Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia | Urology Group | 30306544 | TRUE |
10.1002/14651858.CD012414.pub2 | Oct-18 | Penile rehabilitation for postprostatectomy erectile dysfunction | Urology Group | 30352488 | TRUE |
10.1002/14651858.CD012838.pub2 | Jul-18 | Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review | Urology Group | 30036453 | TRUE |
10.1002/14651858.CD012551.pub3 | May-18 | Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome | Urology Group | 29757454 | TRUE |
10.1002/14651858.CD005010.pub3 | May-18 | Primary cryotherapy for localised or locally advanced prostate cancer | Urology Group | 29845595 | TRUE |
10.1002/14651858.CD008509.pub3 | Apr-18 | Alpha-blockers as medical expulsive therapy for ureteral stones | Urology Group | 29620795 | TRUE |
10.1002/14651858.CD009625.pub2 | Sep-17 | Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer | Urology Group | 28895658 | TRUE |
10.1002/14651858.CD006027.pub2 | Jun-15 | Nonsteroidal anti-inflammatory drugs (NSAIDs) and non-opioids for acute renal colic | Urology Group | 26120804 | TRUE |
10.1002/14651858.CD007044.pub3 | Nov-14 | Extracorporeal shock wave lithotripsy (ESWL) versus percutaneous nephrolithotomy (PCNL) or retrograde intrarenal surgery (RIRS) for kidney stones | Urology Group | 25418417 | TRUE |
10.1002/14651858.CD008973.pub2 | Sep-14 | Topical corticosteroids for treating phimosis in boys | Urology Group | 25180668 | TRUE |
10.1002/14651858.CD004720.pub3 | Jan-13 | Screening for prostate cancer | Urology Group | 23440794 | TRUE |
10.1002/14651858.CD001423.pub3 | Dec-12 | Serenoa repens for benign prostatic hyperplasia | Urology Group | 23235581 | TRUE |
10.1002/14651858.CD004135.pub3 | Sep-12 | Microwave thermotherapy for benign prostatic hyperplasia | Urology Group | 22972068 | TRUE |
10.1002/14651858.CD008007.pub2 | Nov-11 | Lycopene for the prevention of prostate cancer | Urology Group | 22071840 | TRUE |
10.1002/14651858.CD007853.pub2 | Feb-11 | Screening for testicular cancer | Urology Group | 21328302 | TRUE |